Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.
作者信息
Kryscio David R, Sathe Pradeep M, Lionberger Robert, Yu Lawrence, Bell Michael A, Jay Michael, Hilt J Zach
机构信息
Department of Chemical and Materials Engineering, University of Kentucky, 177 F. Paul Anderson Tower, Lexington, Kentucky 40506, USA.
出版信息
AAPS PharmSciTech. 2008;9(1):84-6. doi: 10.1208/s12249-007-9009-5. Epub 2008 Jan 12.
Abstract
摘要
相似文献
1
Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.用于评估局部用制剂结构等效性（Q3）的铺展性测量——技术说明
AAPS PharmSciTech. 2008;9(1):84-6. doi: 10.1208/s12249-007-9009-5. Epub 2008 Jan 12.
2
The case for standardizing the appearance of bioequivalent medications.生物等效药物外观标准化的理由。
J Manag Care Pharm. 2011 May;17(4):321-3. doi: 10.18553/jmcp.2011.17.4.321.
3
Development of performance matrix for generic product equivalence of acyclovir topical creams.阿昔洛韦外用乳膏通用产品等效性性能矩阵的开发。
Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30.
4
Establishing "abuse-deterrence equivalence" for generic abuse-deterrent opioid formulations: A proposed development framework.建立通用型阿片类滥用威慑制剂的“滥用威慑等效性”：一个提议的开发框架。
J Opioid Manag. 2016 May-Jun;12(2):96-100. doi: 10.5055/jom.2016.0320.
5
Bioequivalence of topical generic products. Part 1: Where are we now?局部用仿制药品的生物等效性。第 1 部分：我们现在处于什么位置？
Eur J Pharm Sci. 2018 Oct 15;123:260-267. doi: 10.1016/j.ejps.2018.07.050. Epub 2018 Jul 24.
6
The protein science of biosimilars.生物类似药的蛋白质科学
Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v4-8. doi: 10.1093/ndt/gfl474.
7
Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.评估丙酸倍他米松乳膏和软膏的创新型制剂与仿制药的等效性。
Clin Ther. 1991 Nov-Dec;13(6):687-94.
8
[Bioequivalence of dermatological topical medicines:the Brazilian scenario and the challenges for health surveillance].[皮肤科外用药物的生物等效性：巴西的情况及健康监测面临的挑战]
Cien Saude Colet. 2015 Nov;20(11):3599-608. doi: 10.1590/1413-812320152011.01082015.
9
Light-sensitive drugs in topical formulations: stability indicating methods and photostabilization strategies.局部用制剂中的光敏药物：稳定性指示方法及光稳定策略
Future Med Chem. 2017 Oct;9(15):1795-1808. doi: 10.4155/fmc-2017-0105. Epub 2017 Sep 19.
10
Generic versus brand-name North American topical glaucoma drops.通用名与品牌名的北美局部青光眼滴眼剂。
Can J Ophthalmol. 2012 Feb;47(1):55-61. doi: 10.1016/j.jcjo.2011.12.004.
引用本文的文献
1
Intact NMR Approach Quickly Reveals Synchronized Microstructural Changes in Oil-in-Water Nanoemulsion Formulations.完整核磁共振方法快速揭示水包油纳米乳液制剂中微观结构的协同变化。
AAPS J. 2024 Jul 9;26(4):78. doi: 10.1208/s12248-024-00945-3.
2
Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique.热熔挤出技术制备氟比洛芬固体脂质纳米粒凝胶剂。
AAPS PharmSciTech. 2022 Sep 16;23(7):257. doi: 10.1208/s12249-022-02410-w.
3
Application of Confocal Raman Microscopy for the Characterization of Topical Semisolid Formulations and their Penetration into Human Skin Ex Vivo.共聚焦拉曼显微镜在局部半固体制剂表征及其体外渗透入人体皮肤中的应用。
Pharm Res. 2022 May;39(5):935-948. doi: 10.1007/s11095-022-03245-7. Epub 2022 Apr 11.
4
The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence.局部用半固体制剂药品监管框架的意义：从关键质量和性能属性到生物等效性的确立
Pharmaceutics. 2021 May 13;13(5):710. doi: 10.3390/pharmaceutics13050710.
5
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms.批次间和批次内变异性对证明半固体制剂等效微观结构所需样本量的影响。
Pharmaceutics. 2020 Nov 28;12(12):1159. doi: 10.3390/pharmaceutics12121159.
6
Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence.局部用半固体制剂微观结构参数的批次间变异性评估及其对等效性证明的影响。
Pharmaceutics. 2019 Oct 1;11(10):503. doi: 10.3390/pharmaceutics11100503.
7
Topical Formulation Comprising Fatty Acid Extract from Cod Liver Oil: Development, Evaluation and Stability Studies.包含鳕鱼肝油脂肪酸提取物的局部用制剂：研发、评估及稳定性研究
Mar Drugs. 2016 Jun 1;14(6):105. doi: 10.3390/md14060105.
本文引用的文献
1
Progress in methodologies for evaluating bioequivalence of topical formulations.局部用制剂生物等效性评估方法的进展
Am J Clin Dermatol. 2001;2(5):275-80. doi: 10.2165/00128071-200102050-00001.
2
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.局部皮肤剂型的生物等效性——生物等效性评估方法
Pharm Res. 1998 Feb;15(2):167-71. doi: 10.1023/a:1011941929495.
Zotero 插件